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A B S T R A C T
Valorisation of the efficacy of 9-cis beta-carotene in treating atherosclerosis, psoriasis, and inhibiting ather-
ogenesis and retinitis pigmentosa is becoming increasingly urgent, but supplies of 9-cis beta-carotene are scarce
and this compound is difficult to synthesise chemically, unlike the much more common all-trans form. Innovative
products, processes and services in an algal biorefinery that rely on renewable biological resources instead of
fossil fuel alternatives offer the potential to lower the energy costs of traditional chemical processes and reduce
carbon emissions, water usage and waste. In 2013, the European Commission supported development of 4
microalgal biorefinery projects to assess the potential for innovative approaches to tackle the major challenges
intrinsic to the development of the algae biorefineries. One of these was the D-Factory (KBBE.2013.3.2-02)
which sought to evaluate requirements for sustainable, industrial-scale production of Dunaliella salina and ex-
traction of its carotenoids, especially 9-cis beta-carotene in a CO2 microalgae biorefinery. Here we present
findings of the D-Factory project and propose a way forward for industrial-scale production of 9-cis beta-carotene
using biotechnology based on Dunaliella salina biomass. Cultivation improvements are able to deliver more than
double the current levels of productivity, with increased sustainability, whilst the use of natural hyper-accu-
mulating carotenogenic strains combined with the use of red light to boost production of the beta-carotene
pathway, will increase the relative concentration of 9-cis beta-carotene in extracts of carotenoids with con-
sequent improvements in downstream processing. These developments pave the way for acquiring data for a
Medicine Licence and prepare the market for entry of novel 9-cis beta-carotene products.
1. Background
In the field of biotechnology, the use of microalgal biomass re-
sources is evolving exponentially through research efforts to exploit
algal metabolism to synthesise and accumulate a wide range of com-
pounds of industrial interest, as well as lower the energy costs of tra-
ditional chemical processes and reduce carbon emissions, water usage
and waste [1]. However, to realise the ‘green gold’ potential of mi-
croalgae successfully and establish the validity of green approaches
over fossil-based systems, requires strategic planning. In 2013, the ex-
ecutive branch of the European Union, the European Commission,
supported development of 4 microalgal biorefinery projects to assess
the potential for innovative approaches to tackle the major challenges
intrinsic to the development of the algae biorefineries for production of
high value-added products such as polymers, pharmaceuticals, oils and
chemicals, bioactive compounds and colorants. A further aim was to
deliver a robust scientific and technological basis for substantiating
strategic decisions for the industrial development of algae for high
added-value products.
One of these was the D-Factory (KBBE.2013.3.2-02) [2], which
sought to evaluate requirements for sustainable, industrial-scale pro-
duction of Dunaliella salina and extraction of its carotenoids, especially
9-cis β-carotene, in a CO2 microalgae biorefinery.
1.1. The carotenoid 9-cis β-carotene
Carotenoids are conjugated isoprenoids which are synthesized by all
photosynthetic organisms for light-harvesting and for photo-protection.
Carotenoids that contain at least one unsubstituted β ring are critical for
the vitamin A pathway and needed in the human diet to produce re-
tinoids [3]. These play important roles in cell differentiation, growth,
and apoptosis (for reviews see [4–7]). They are also critical for con-
trolling vision defects [8]. Intact carotenoid molecules and carotenoid
cleavage products other than retinoids may also act as lipid radical
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scavengers and as singlet oxygen quenchers to protect against oxidant
stress [9], as well as act as blue light filters for photoprotection of eyes
and skin [10]. They are also attracting interest as promoters of cogni-
tive functions [11]. The carotenoids market is projected to grow to USD
2.0 billion by 2026, largely due to increasing use of natural carotenoids
especially β-carotene as food colorants, and to innovations in extraction
technologies [12].
9-cis β-carotene is one of the most potent precursors of retinoids.
Recent evidence has suggested that 9-cis β-carotene might serve as an
effective treatment for a range of retinoid dystrophies, including type 2
diabetes, obesity, certain types of cancer (breast, cervical, ovarian,
colorectal), mild, chronic plaque psoriasis and a range of cardiovascular
diseases [13–24]. With an aging society across Europe and much of the
world, the development of an effective product to treat life-changing
conditions and combat common eye disease and blindness would bring
significant societal benefits. Atherosclerosis is a chronic inflammatory
disease of the arteries and underlying cause of ~50% of all deaths in
westernized society. An estimated 17.9 million people died from Cardio
Vascular Diseases in 2016, representing 31% of all global deaths. Of
these deaths, 85% were due to heart attack and stroke (WHO). Retinal
degeneration affects millions of people in Europe and world-wide,
leading to substantial social and economic burden. Based on [25] we
estimate that more than 288 million people around the world will suffer
from vision loss due to an inherited retinitis pigmentosa and age-related
macular degeneration.
9-cis β-carotene, however, is scarce and difficult to synthesise che-
mically, unlike the much more common all-trans form. The current
state-of-the-art production of 9-cis β-carotene is via an 8-step chemical
synthesis based on β-cyclocitral and all-trans retinal afforded by the
Wittig reaction of all-trans retinal and 9-cis-retinyl triphenylpho-
sphonium bromide salt [24]. The relative difficulty in synthesis of 9-cis
β-carotene is reflected by a price comparison of the two products cur-
rently marketed by Sigma-Aldrich (Merck), namely, €6/g for the all-
trans form, compared to €500,000/g for 9-cis β-carotene.
Cultivation of1 D. salina could offer a solution, because it produces
β-carotene in high concentration of cis/trans (Z/E) configurations, ~1:
1 (see Table 1) and will accumulate up to 10% of the dry biomass as β-
carotene [26–29]. Furthermore, it grows in extreme, salt-water condi-
tions around the globe, at extreme temperatures from around −5° to
above 40 °C and at salt concentrations up to NaCl saturation, which
cannot be used for agriculture for food production [26]. In these rela-
tively simple hypersaline ecosystems, competition for resources is re-
duced compared to freshwater systems and the risk of culture crash can
be rapidly controlled with NaCl addition: D. salina grows optimally at
10–15% salt but will also grow at salt concentrations up to saturation
and will dominate ecosystems at the highest salinities where it lacks
competitors. Increased salinity up to 25% are typically applied in cul-
tivation to control predators and to optimise carotenogenesis. Conse-
quently, Dunaliella can be cultivated in open pond raceways (OPRs),
which have lower construction costs and are more easily maintained
compared to closed vessel photobioreactors (PBRs) [30]. Cultivation of
D. salina for 9-cis β-carotene could therefore reduce the capital ex-
penditure (CAPEX) of 9-cis β-carotene production several 10's -fold
compared to that required for chemical synthesis and represent a sig-
nificantly more environmentally-sustainable solution for 9-cis β-car-
otene production. Cultivation would also lend itself to scale-up pro-
duction using resource-efficient, low-cost raceways with commensurate
increase in CO2 fixation by photosynthesis.
Nature Beta Technologies (NBT) (Ltd) (Israel) currently produces
~25 t Ash Free Dry Weight (AFDW) D. salina var bardawil biomass per
annum from 10 Ha of raceways and represents one of the largest reli-
able sources of D. salina powder in the world [2]. However, the powder
is not cultivated for high 9-cis β-carotene content. Monzon Biotech
S.R.L. (MB) in Spain produces ~400 kg p.a (AFDW) D. salina for es-
tablished markets, but current biomass productivity ranges of D. salina
lie between 0.75 g m−2 d−1 and 3.0 g m−2 d−1 (AFDW) depending on
seasonality and other factors [2]. Other sources of Dunaliella car-
otenoid-containing products exist e.g. Betatene produced by BASF,
which is extracted using only natural plant oil, and Solgar Natural
Source Oceanic Beta Carotene Softgels, but these are of variable quality
(9-cis β-carotene/all-trans βC-carotene = 0.4 or less).
1.2. Biorefinery challenges for producing 9-cis β-carotene by D. salina
Three challenges/questions for producing 9-cis β-carotene in a
biorefinery were envisaged at the start of the D-Factory project:
1.2.1. Question 1: Can the biomass yield of D. salina be increased
sustainably?
Reproducible, low-cost production of D. salina biomass with a
consistently high relative content of 9-cis β-carotene would be required
to convince the manufacturing sector of the commercial viability of
adopting new processing practices and engaging with new value chains,
and to persuade investors of the viability of investing in new ‘farming’
practice. It would also be required to support acquisition of a Medicine
Licence to underpin nutraceutical claims and drive market demand for
products. Furthermore, whilst the expected biomass productivity of
microalgae, as a whole, has been estimated at ~25 g m−2d−1 based on
an estimated 3% photosynthetic efficiency, solar intensity of
4000 kcal m−2d−1 and algal calorific value (5 kcal g−1) [31], this is
approximately 8-fold greater than achieved by most commercial op-
erators.
Dunaliella carotenogenesis is a stress condition dependent on the
light/cell ratio and on the nitrate/cell ratio and salinity [32–35].
Consequently, production tends to vary as a function of season, the
availability and nature of nutrient nitrogen supplied, and the level of
CO2, which poses problems for commercial production. With increasing
temperature, CO2 solubility in water is reduced and, at the high tem-
perature and pH usually found in the natural brines in which Dunaliella
grows, the bulk of the inorganic carbon (> 99%) is in the form of
HCO2/CO3−2 and is less available for uptake. Below 30 °C, CO2 con-
sumption of 10 g m−2 d−1 is typical for an alga production of 2 g m
−2d−1, giving a CO2 Mass Transfer = 5 g/g, but at temperatures>
30 °C the CO2 Mass Transfer can reach>10 g/g. Also, above tem-
peratures of 35 °C, glycerol tends to leak from cells, which will support
the growth of halophilic heterotrophs including fungi, yeasts and ha-
lophilic Archaea (family Halobacteriaceae). Carotenogenic cultures are
also much more sensitive to the chemical and mineral composition of
the brine and turbulence compared to non-carotenogenic cultures.
Since Dunaliella grows well below 16 °C, and the Q10 of photo-
synthesis is quite stable at low temperatures, growth rate can improve
with temperature control below 30 °C. Also, lower cultivation tem-
peratures favour increased β-carotene content and higher relative ratio
of 9-cis β-carotene with no significant changes in the other cell pig-
ments [36].
Table 1
β-Carotene content and isomeric composition.
Source β-Carotene content
% AFDW
β-Carotene composition (%)
All trans β-carotene 9-cis β-carotene
Synthetic 100 >98 <2
Carrot 0.01–0.06 50 2
Palm oil 0.06–0.07 36 24
Dunaliella 6–14 50 >40
1 Dunaliella salina throughout this manuscript represents also its variant
Dunaliella bardawil.
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1.2.2. Question 2: Can 9-cis β-carotene be separated cleanly and in high
yield from other components of harvested D. salina biomass?
Carotenogenic D. salina biomass after harvest contains a range of
polymers in addition to glycerol and carotenoids, which need to be
separated from 9-cis β-carotene (See Table 2).
Secondly, the conjugated polyene chain that is characteristic of
carotenoids makes carotenoids susceptible to oxidative degradation
[37]. Polyunsaturated lipids including omega-3 essential fatty acids, are
also highly oxidizable. Currently the most commonly used extraction
methods include organic solvent extraction, which is often assisted by
heat, pressure, microwave or ultrasound for cell disruption; and sub-
and supercritical fluid extraction [38–42].
The use of supercritical CO2 (scCO2) to extract carotenoids from
biomass minimises exposure to oxygen, is inert, readily available in
pure form, and easily removed from products, and selective extractions
are possible because the solubility of many extracted compounds in CO2
varies with temperature and pressure. Use of scCO2 also overcomes
limitations to the solubility and polarity spectrum imposed through
using the diminishing range of acceptable organic solvents [40,41].
Spent biomass is also stable, because it is defatted, reducing the risk of
rancidity and enriched in the more polar polyphenols and proteins.
However, the use of scCO2 is not suitable for cells with a high-water
content [42], consequently biomass would need to be dried, which is
energy-intensive.
9-cis β-carotene also shares very similar chemical properties with
all-trans β-carotene, the other major carotene present in carotenogenic
biomass. Few reports exist on industrial-scale separation of 9-cis β-
carotene from other carotenoids. Haigh (2000) [43] patented separa-
tion of a carotenoid extract on a deactivated alumina chromatographic
column followed by crystallisation of all-trans-β carotene to obtain
preparations comprising 50–75% 9-cis β-carotene and up to 40% all-
trans-β carotene and Sibeyn & De Pater, 2002 [44] patented the tem-
perature-induced crystallisation of all-trans-β-carotene at low tem-
perature to obtain β-carotene crystals ≥90% purity from Blakeslea
trispora.
1.2.3. Question 3: Can 9-cis β-carotene be produced sustainably in a
biorefinery with lower energy costs compared to traditional chemical
processes, and reduced carbon emissions, water usage and waste?
Apart from 9-cis β-carotene, the carotenoid complement of D. salina
may include the colorless carotenoids phytoene and phytofluene, lutein
and zeaxanthin, and α-carotene, depending on culture conditions.
Phytoene and phytofluene are rarities among naturally synthesized
carotenoids [10] but ideally suited to protect the skin against long wave
ultraviolet A (UVA) and short wave ultraviolet B (UVB) and offer an-
tioxidant and anti-inflammatory effects [45,46]. Currently more than
90% of the active ingredients in cosmetics are still of synthetic origin.
The human macula uniquely concentrates three carotenoids: lutein,
zeaxanthin, and meso-zeaxanthin. Lutein and zeaxanthin must be ob-
tained from dietary sources whilst meso-zeaxanthin is believed to be
formed at the macula by metabolic transformations of ingested car-
otenoids. Clinical trials using lutein and zeaxanthin supplements results
in augmentation of macular pigment and consequential benefits in vi-
sual performance whilst consumption of lutein- and zeaxanthin-rich
products is associated with lower incidence of cancer, cardiovascular
disease, Age-related Macular Degeneration and cataract formation.
Lutein is clinically proven to prevent cataract and macular degenera-
tion and may function as an anti-oxidant to decrease around 60 chronic
disease risks [47].
α-Carotene has proven anti-metastatic action, which is not asso-
ciated with provitamin A activity, which may involve the mediation of
gene expression and signalling pathway related to invasion and mi-
gration [48].
The biomass components once separated from carotenoids also
present several opportunities for use as by-products. For example, al-
though use of scCO2 uses high temperature and pressure which de-
natures proteinaceous enzymes, the proteins once separated contain the
ten essential amino acids required by animals and humans in their diet
[2] (see Table 3). The lipid profile of the powder also indicates value for
food, or feed with a high relative content of omega-3 fatty acids [2]
(Table 4). Additionally, in a 1000-chick feed study, a low additive in-
clusion level of D. salina defatted powder (0.1–1% w/w) prepared after
scCO2 extraction of D. salina biomass displayed bioactive properties
Table 2
Typical composition for Dunaliella from the D-Factory, Ash-free dry weight basis (AFDW) [2].
Total protein
g kg−1 AFDW
Total Lipid
g kg−1 AFDW
Total carotenoids g kg−1 AFDW Carbohydrate
g kg−1 AFDW
Glycerol
g kg−1 AFDW
200–300 100–200 60–90 500–800 >100
Table 3
Amino acid profile of D. salina.
Category Amino acid % of total amino acids
Essential amino acids Histidine 2.6
Isoleucine 5.7
Leucine 7.3
Valine 6.3
Lysine 2.1
Phenylalanine 11.5
Methionine 2.1
Threonine 7.3
Tryptophan 2.6
Conditionally essential amino acids ⁎Arginine 2.6
Tyrosine 1.0
Cystine 2.1
Glutamic 10.4
Glycine 9.4
Proline 1.0
Non-essential amino acids Alanine 7.3
Aspartic 18.2
Serine 0.5
⁎ Also essential in the diet of animals.
Table 4
Fatty acid profile of D. salina.
Identified fatty acids % of TFA Identified fatty acids % of TFA
C08:0 caprylic acid 0.00 C18:1 Oleic Acid 5.81
C10:0 capric acid 0.00 C18:2 Linoleic Acid 4.91
C11:0 undecylic acid 5.62 C18:3 Linolenic Acid 17.65
C12:0 lauric acid 0.15 C18:4 Stearidonic Acid 0.26
C13:0 tridecylic acid 0.67 C20:0 Arachidic Acid 0.46
C14:0 myristic acid 1.77 C20:1 Gadoleic Acid 1.18
C14:1 myristoleic acid 0.32 C20:4 Arachidonic Acid 0.00
C15:0 pentadecanoic acid 0.12 C22:0 Behenic Acid 0.31
C15:1 pentadecenoic acid 0.10 C20:5 Eicosapentaenoic Acid 0.00
C16:0 palmitic acid 33.69 C22:1 Erucic Acid 0.00
C16:1 palmitoleic acid 0.72 C22:4 Adrenic Acid 0.00
C17:0 heptadecanoic acid 0.30 C24:0 Lignoceric Acid 0.00
C17:1 heptadecenoic acid 3.21 C22:5 Docosapentaenoic acid 0.00
C18:0 stearic acid 1.77 C22:6 Docosahexaenoic Acid 0.00
Unidentified fatty acids 20.98
Total saturated fatty acids 44.86
Total monounsaturated fatty acids 11.34
Total polyunsaturated fatty acids 22.82
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when fed to male broiler chickens. Chicks fed on diets with 0.1% de-
fatted powder compared to those fed without showed a significant
improvement in feed conversion ratio and a significant gain in weight
[49]. These beneficial effects were depressed, and negative responses
were observed at higher ingredient levels suggesting a product which
might be used at low dose to help in the drive to find alternatives to
antibiotics (now banned) in animal feeds.
However, realisation of the value of by-products presents several
hurdles. For instance, although Dunaliella powder was granted GRAS
(Generally Recognized as Safe) status [50] this does not automatically
ensure European acceptance of novel food ingredients derived from this
alga. The European Food Safety Authority (EFSA) defines novel foods as
food that European citizens have not consumed to a significant degree
prior to May 1997. It includes food from new sources, food obtained
through the application of new technologies or by using new substances
and the current European Union (EU) regulations on Novel Food (2015)
specifically refers to food consisting of, isolated from or produced from
algae.
Approval of algae-based biomass and derived extracts is currently
the main bottleneck tending to reduce the potential of algae biomass as
a food/nutraceutical resource. It requires complex and expensive dos-
siers to deliver complete characterization of independent batches of
products including stability analysis and safety studies; review of the
safety of the product, its source and its compounds; and evidence per-
taining to Absorption, Distribution, Metabolism and Excretion. There is
only a limited number of authorized algae products that have been
approved and this also limits the growth of the Algae sector.
The legislation pertaining to animal feed is equally onerous: it ap-
plies principally to feed for farmed livestock, but also covers feed for
horses, pets, farmed fish, zoo and circus animals, and creatures living
freely in the wild and addresses the nutritional claims that can be made
for certain feed products and the additives (including vitamins, color-
ants, flavourings, binders) authorized for use in animal feed. Regulation
(EG) Nr. 767/2009: regulates All Feed Material; Regulation (EU) Nr.
68/2013: Catalogue of All Feed Material; and Regulation (EG) Nr.1831/
2003: Regulates e.g. coloring agents, nutritional components currently
apply to Dunaliella. Vitamins, provitamins and chemically well-defined
substances having similar effect are however recognized (2015).
Cosmetics are covered under REACH (Registration, Evaluation,
Authorisation and Restriction of Chemicals): only chemicals that are
registered are permitted for production, import, marketing and
application. Biological materials such as scCO2 extracts of carotenoids
currently fall under the category of “substances with unknown or
variable composition, complex reaction products, biological material
whose chemical composition cannot identified sufficiently because the
amount of ingredients is high; the major amount of the composition is
unknown; and/or composition may vary significantly. A lipid-based
anti-aging skin product from D. salina is however marketed by DSM
through their acquisition of Pentapharm (Switzerland) [51].
Techno-economic, social and environmental assessments of sus-
tainability represent important tools with which to assess new tech-
nologies for unwanted effects or potential damage of any of the tech-
nological innovations that might be introduced. When integrated, those
technologies or gaps in technology that impact significantly on the
sustainability of the whole are highlighted in order to allow further
improvements for sustainability in a continuous cycle. The assessment
is also future-oriented and recognises that innovations in technology
will not be perfected within the current time frame of a given project.
Technology assessments are difficult if not impossible to carry out in
an objective manner since subjective decisions and value judgments
have to be made regarding a number of complex issues such as (a) the
boundaries of the analysis (b) the selection of appropriate indicators of
potential positive and negative consequences of the new technology. To
minimise the tendency for bias by values of the most powerful stake-
holders, i.e. the developers and proponents of the new technologies
under consideration, the D-Factory project partners held a workshop to
review technology status and evaluate findings to date. All partners
were offered the chance to score technologies in an anonymous way.
This also provided the opportunity for new technologies to be brought
forward. From this exercise a set of 6 scenarios were developed for
sustainability assessments based on integrated designs for construction
of a fully operational industrial scale D-Factory facility in year 2025,
and operation of a 20 Ha site producing a total algal culture volume of
993,600 m3 (50 t AFDW powder y−1 or 167 kg d−1), for 25 d month−1
for 12 months i.e. 300 d y−1. For this exercise, data were required.
Carotenoids, lipids and glycerol comprised the product portfolio, and
centrifuges, supercritical fluid (scCO2) extraction, solvent extraction,
liquid-liquid extraction, membranes and chromatography were the
main involved technologies. Some of the main points that were taken
into consideration in developing the scenarios are highlighted below,
but for full details the reader is referred to [52]. The base case scenario
for the biorefinery process envisaged the following steps and Fig. 1
Fig. 1. Schemes to illustrate the 6 scenarios devised for sustainability assessments.
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illustrated the 6 scenarios that were developed for sustainability as-
sessments:
• Evodos-type spiral plate centrifuge for harvesting cells• Membrane technology as a pre-concentration step for harvesting
cells to lower energy costs and permit effluent recycle• Controlled cell rupture using water, which also washes biomass to
remove salt• Biomass is dried - drying step uses spray-drying• Supercritical CO2 (scCO2) and organic solvents are used to frac-
tionate extracts into increasingly pure preparations of high-value
compounds.
The products and reference products for the assessments is shown in
Table 5.
The economic assessment analysed CAPEX (fixed capital investment
+ working capital or working capital investment); OPEX (direct or
variable production costs, fixed production costs, general expenses);
products' prices based on market analysis and determined Net Present
Value (NPV), the Internal Rate of Return (IRR), the Breakeven Revenue
and the product contribution margin. In the absence of a market value
for 9-cis β-carotene, the price of lutein (€1470/kg) was used as a marker
for working out a price equivalent, although this should increase with
the expected certified health claims.
For calculation of the NPV, the net operating cash flows over the life
of the project were summarized based upon the sales income and op-
erating costs excluding all costs which did not represent a cash move-
ment e.g. depreciation costs. The capital investments required to build
the biorefinery plant was then added to this cash flow. The cash flow
was then discounted at a discount rate which represented the oppor-
tunity costs of investing in an alternative project. The economic as-
sessment used a discount rate of 5% as per EU guidelines. The NPV is
then the sum of the discounted cash flows. The decision criterion for the
evaluation of an investment project is that the NPV should be at least
zero or positive.
The IRR is the discount rate at which the NPV is just equal to zero.
The higher the IRR, the more favourable the investment project appears
because it implies that future cash flows could be discounted at a higher
discount rate until the NPV would become zero. An IRR of 25% is
generally considered “as the threshold for securing capital investment
in new processing technology”. This threshold was used as a benchmark
which the D-Factory would have to achieve in order to become at-
tractive for investors. If a given scenario failed to achieve this threshold
return the increase in the product prices required to achieve this
threshold return was calculated.
The breakeven revenue is the revenue required for the business to
cover its costs. Breakeven revenue equals the fixed costs divided by the
gross margin ratio and consequently reflects the sales required to cover
both the direct costs of production and the fixed costs of operation. The
business only starts making a profit once sales rise above the breakeven
revenue.
2. Outcomes
Outcomes from the D-Factory are described below with reference to
the 3 questions posed:
(1) Can the biomass yield of D. salina be increased sustainably?
(2) Can 9-cis β-carotene be separated cleanly and in high yield from
other components of harvested D. salina biomass?
(3) Can 9-cis β-carotene be produced sustainably in a biorefinery with
lower energy costs compared to traditional chemical processes, and
reduced carbon emissions, water usage and waste?
2.1. Can the biomass yield of D. salina be increased sustainably?
A coastal D-Factory pilot with geo-textile lined OPRs fitted with
paddlewheels, sensors and monitor was established (Fig. 2) [2].
These held sea- and salt-water maintained at 10–15% salinity to
cultivate the halophytic algae and liquid pressurized CO2 was bubbled
in for carbonation for algal growth. Algae were harvested by partially
or completely draining the raceways using centrifuges and the biomass
was stabilised by spray-drying techniques. The OPRs were operated for
300 days per year, in winter (5 °C–15 °C) and summer (> 40 °C) and
wastewater containing high salt loads and organic matter was treated in
aeration and settlement ponds then filtered before reuse or discharge to
the sea. Spent water cannot be discharged to sea without strict legis-
lative control of the BOD and COD. Artemia were controlled with traps
and with modulation of environmental parameters including increase in
salinity: to allow continuous summer production the salt concentration
was increased to above 18%. On the other hand, protozoa infestation
was not as easily controlled; protozoa are common in all marine salts
Table 5
Overview of products and reference products [52].
Products Market Reference product
Polar-lipids, non-polar lipids, free fatty acids Specialist animal feed Surfactants Rapeseed oil
Defatted powder Feed Soy + cereals
Lutein Nutraceutical Lutein purified from marigold
Zeaxanthin Nutraceutical Zeaxanthin purified from marigold
Chlorophyll Food colorant Extracts from green plants such as spinach
All-trans β-carotene Food colorant Synthetic all trans β-carotene
9-cis β-carotene Pharmaceutical
Sensitivity: Nutraceutical
Standard: none (novel product)
Sensitivity: like all-trans β-carotene
α-carotene Nutraceutical Like all-trans β-carotene
Glycerol Multiple Generic substituted chemicals
Fig. 2. A coastal D-Factory pilot facility set within the NBT (Ltd) Production
site in Eilat, Israel. Lined raceways 150 m long x 4 of 5 m width, fitted with
paddlewheels, hold sea- and salt- water to a depth of ~20 cm. Local strain,
Dunaliella bardawil.
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and in all ocean or marine waters. They come as cysts and cannot be
eliminated; the only protozoa-free marine salt available is costly, kiln-
dried salt.
Using ideal materials as well as a new cost-efficient raceway design
and new techniques to control predators and reduce costs in effluent
management, the productivity of the alga was doubled: in spring, ty-
pical yields were ~300 mg carotene m−2 d−1, (carotenoid: chlorophyll
ratio ~10), which at ~8% AFDW carotene content amounted to approx.
4 g AFDW biomass m−2 d−1. Dried biomass was stable for at least
1 year, stored in the dark at −18 °C, in food-grade polyethylene bags
held under vacuum. Biomass could therefore be harvested, washed free
of salt on site for reuse, and dried to a powder and batches of the
powder could be stored and blended before extraction to reduce sea-
sonal variation in biomass quality.
The knowhow to cultivate natural strains of halophytic Dunaliella in
OPRs was transferred to a second inland facility [2], which offered the
opportunity to assess the use of flue gas CO2 for carbonation for algal
growth and the use of salt from an underground salt-mine. Flue gas CO2
was bubbled from natural gas combusted in a local 14 MW CHP plant
(up to 7% CO2), which also supported a heating system designed for
temperature control in winter. Furthermore, the salt mined from the
underground caverns was protozoan cyst-free and treated wastewater
could be injected back into empty underground salt caverns.
Cascade raceways (capacity 15m2, 525 L) were also tested but
achieved only a marginally better biomass productivity of 4.4 g m2 d−1
in pilot scale and were heavily dependent on inputs of fresh water to
compensate for evaporative losses which, using thin (4 cm) layers of
culture impacted significantly on salinity [2].
For development of high density inoculum, tubular PBR's were
tested: these should increase volumetric productivity because a shorter
light path length can be applied. However, they rapidly became fouled
when algal glycerol leaked from the wall-less algae and supported
heterotrophic growth of halotolerant bacteria, yeasts and other fungi.
Increasing the salt concentration as a measure to control predators also
increased the glycerol content and the attendant production of biofilms
which were difficult to clean from the insides of the tubes without the
availability of in situ technology. Flat-panel PBRs however, supported
good growth of orange carotenogenic Dunaliella for inoculation and the
plastic bags could be discarded once contaminated.
Under continuous light with non-limiting CO2, biomass yield in-
creased but was not sustainable because photosynthetic and respiratory
systems of the algae were damaged [53].
The sustainability assessment concluded that savings of up to 90%
of greenhouse gas emissions and other environmental impacts, com-
pared to the state of the art, seemed achievable over the next years for
Dunaliella biomass production. Specific findings included the following
(see [54] for full details):
• On-site solar power or renewable steam production from geothermal
energy at certain locations could significantly decrease fossil-based
energy input and related GHG emissions - up to almost zero.• Fresh water (or seawater) use may be reduced with efficient medium
recycling, reducing costs and environmental burdens.• Wastewater treatment requires land, but the amount of treatment
needed may be minimised by harvesting cells intact.• Raceways require complete ground sealing and could be sited on
sealed, disused, industrial brownfield sites instead of agricultural
land.• CO2 from the combustion of natural gas direct flue gas injection does
not need flue-gas treatment and does not impact on FDA or reg-
ulatory approval for algae-derived products. However, if the dec-
arbonisation policy direction initiated today is successfully im-
plemented in the coming decades, increasingly few CO2 sources will
be available for CO2 utilisation from exhaust gases in the future.• Integration of an algal biorefinery with existing facilities for pro-
ducing salt products or seawater desalination facilities minimises
the environmental burdens of energy and material use, impacts on
local freshwater availability and disposal of saltwater as well as
efforts for regulatory compliance.
2.2. Can 9-cis β-carotene be separated cleanly and in high yield from other
components of harvested D. salina biomass?
scCO2 technology requires algal biomass in powder form for pro-
cessing, so shipping powders to industrial scale scCO2 facilities, which
are CAPEX intensive, overcame a logistical hurdle. However, lyophili-
sation was too costly for industrial-scale purposes. Spray-drying tech-
nology offered a lower cost solution, provided the particle size was
adjusted to suit scCO2 technology, since fine (100-300 μm) free-flowing
powders proved to be too powdery for the flow-through of scCO2, and
caused blockages in the extractor. Spray-dried particle size is, however,
adjustable to meet size criteria needed for scCO2 extraction.
Using lyophilised powders of Dunaliella biomass, the use of scCO2
yielded enriched extracts of high-value carotenoids for formulation
testing and defatted powders for by-product development (Fig. 3).
Annually a minimum of 100 t of biomass can be processed in 185
working days. The oily extract typically represented 16–17% by weight
of total algal biomass. Around 30% of this extract was made up of
carotenoids, of which> 87% were hydrophobic carotenes. 9-cis β-car-
otene was particularly enriched in carotenoid extracts (9-cis β-carotene:
all-trans βC ~1.5). However, ~50% of the oil remained in the defatted
powder and included xanthophylls. Linolenic acid (18:3), linoleic acid
(18:2), oleic acid (18:1) and palmitic acid (16:0) were the predominant
fatty acids in both defatted powder and extract.
Using petrochemical solvents, polar and non-polar combinations of
solvent (methanol or acetone followed by hexane; MTBE-methanol)
extracted almost all carotenoids present in biomass (91%), but extracts
were not as enriched in carotenoids as for scCO2 extracts. Extracts ty-
pically represented ~35% by weight of the total material and contained
~14% total carotenoids.
From results of further fractionation to obtain increasingly enriched
preparations of individual carotenes and xanthophylls based on com-
binations of solvent, counter current chromatography (HPCCC) and
preparative HPLC technologies, and the use of solvent resistant mem-
branes to remove solvent, an integrated purification strategy was de-
vised with the aim of scale-up.
Separation challenges were solved in analytical and laboratory-scale
separations but proved extremely challenging in scale-up. The purified
carotenes were also unstable to light and oxygen and increasingly un-
stable on purification from lipids. 9-cis β-carotene could not be sepa-
rated from other carotenes using HPCCC due to their similar partition
coefficient in the range of solvents systems tested. Instead, a strategy
using preparative HPLC was developed, whose success ultimately de-
pended on the nature (concentration of 9-cis β-carotene) in the starting
material. Separations were characterized by low product yields, long
100T Powder
Supercrical 
CO2
16T extract, 
~30% 
carotenoid
84T residue, 
~3% 
carotenoid
Petrochemical 
solvents
35T extract, 
~14% 
carotenoid 
65T residue, 
~1% 
carotenoid 
Fig. 3. Schematic to illustrate the effect of extraction with scCO2 compared to
the use of non-polar and polar petrochemical solvents on the yields of extract
and defatted powder (residue) and concentration of carotenoids.
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run times and low loading capacity (1.8 g sample for a 50 mm diameter
column). Purified preparations of 9-cis β-carotene could be obtained
which represented 94% of total carotenoids detectable using a photo-
diode array detector, but only 82% w/w of the dry matter because of
the presence of lipids which formed an apparent super-structure with 9-
cis β-carotene. These preparations were stable for up to 3 months at 4 °C
in petrochemical solvents but degraded readily in the presence of water
containing oxygen and light.
HPCCC and HPLC technology were difficult to model quantitatively
for the sustainability assessment because important experience from
operation at scale was not available. An analysis of the environmental
impacts, however, clearly showed that the full sequence of downstream
processing steps would impose enormous burdens, dominating climate
impacts of the whole life cycle by far, with the largest emissions coming
from preparative HPLC. Alternative scenarios which produced fewer
products and delivered 9-cis β-carotene as a mixture, saved energy and
solvents.
2.3. Can 9-cis β-carotene be produced sustainably in a biorefinery with
lower energy costs compared to traditional chemical processes, and with
reduced carbon emissions, water usage and waste?
From the economic assessment of sustainability, improvement of
productivity in the ponds from 3 to 5 g m−2 d−1, could be expected to
generate a 27% profit margin, provided the costs of production of 9-cis
β-carotene could be lowered and the market for 9-cis β-carotene pro-
ducts could be developed. Costs of production of 9-cis β-carotene were
excessive because of the technological difficulties that arose in separ-
ating the β-carotene isomers using HPLC.
The main source of biorefinery waste was identified as glycerol,
soluble protein and lipid arising from cytosolic cell biomass released
from ruptured cells harvested using Westfalia-type disc stack cen-
trifuges. Before discharge to water bodies wastewater effluents require
treatment to meet local legislation. High salt effluents are corrosive and
the number of active bacterial species for aerobic treatment is restricted
to halophiles, which precludes anaerobic digester treatment at high salt
concentrations. Depending on land availability and capital investment,
an aerobic treatment system combined with a membrane bioreactor to
remove suspended solids and chemical oxygen demand (COD) was re-
commended. Wastewater effluents may alternatively be reused if
harmful organisms can be destroyed or removed along with any in-
hibitory chemicals. Table 6 provides a summary of waste treatment
options.
Wastes could be minimised: harvesting cells intact using Evodos
spiral plate centrifugation offered the opportunity to recover enzyme
and polar lipopolysaccharide by-products, as well as reduce costs of
effluent waste management. However compared to use of a disc-stack
centrifuge, which harvested biomass at 12,000 L h−1 spiral plate cen-
trifugation caused losses of 9-cis β-carotene due to overheating and long
processing times. The Evodos T50 continuous harvesting prototype
harvested cells at 2500 L h−1, with 95% separation efficiency,> 20 h
d−1 and pastes comprised of up to 40% solids with cells ~90% intact.
The Evodos batch-type T10, harvested cells optimally at 350 Lh−1, with
95% separation efficiency (20–30% solids in pastes with cells> 95%
intact). Evodos-harvested powder was also less-easily processed using
scCO2 due to the presence of salt in the unwashed lyophilised biomass.
A two-step approach which integrated an ultrafiltration polysulfone
membrane unit with Evodos spiral-plate centrifugation was tested to
see if this could offer improvements in minimising waste. Based on a
concentration factor of 5 and an average permeate flux of
22 L m−2 h−1, a reduction of the OPEX+ CAPEX of 52% and reduction
of energy consumption of 66% could be achieved using the two-step
approach compared to the use of the spiral-plate technology alone
[55,56]. However, the more fragile carotenogenic cells now tended to
rupture. Downstream processing with supercritical CO2 will generate a
small loss only of CO2, because most is recovered by condensation and
re-used in the process. Wastes from downstream processing with sol-
vents (HPLC, HPCCC) can be minimised by implementing solvent re-
cycling combined with the use of membranes to recover solvents.
3. Going forwards
Biobased production of 9-cis β-carotene by cultivation of the pho-
toautotrophic, halotolerant microalga, D. salina could deliver extra-
ordinary increases in resource efficiency and environmental impact
reductions, compared to energy- and resource-intensive chemical
synthesis of 9-cis β-carotene and delivers preferred qualities compared
to synthetic forms. However, the technology for downstream processing
still requires development.
Significantly, costs could be reduced if scCO2 extracts were further
enriched in 9-cis β-carotene. Two routes may be envisaged:
3.1. Use of strains selected for high relative content of 9-cis β-carotene
Under controlled laboratory conditions algal strain was identified as
the most important factor influencing carotenoid production. Mutants
that were developed in the laboratory using a classical mutagen, 5-
Bromouracil, when tested outdoors in OPRs were either unable to
compete with prevailing natural strains or to withstand environmental
conditions. By contrast all D-Factory strains of Dunaliella that were
isolated from natural environments were cultivated successfully in
small scale from the laboratory to medium size 100 m2 OPRs. These
data imply that the most practical approach for tailoring cultivation at
scale would be one that was based on cultivating locally sourced hyper-
carotenogenic strains selected for high 9-cis β-carotene.
In the D-Factory 27 new monoclonal Dunaliella strains were isolated
from saline waters and preserved successfully using new cryogenic
methods, despite the absence of a cell wall and presence of delicate
flagellae. They are now catalogued in the D-Factory reference library
and available to the general public by application to the Marine
Biological Association Culture Collection (https://www.mba.ac.uk/
facilities/culture-collection#b56). The strains have been uniquely
identified in a phylogenetic tree developed using molecular bar-coding
and also shown to differ in comparative studies of their growth and
ability to accumulate high contents of individual carotenoids, chlor-
ophyll and glycerol when cultivated under strictly-controlled labora-
tory conditions [57,58].
3.2. Cultivation with red light
The problem of variable microalgal biomass quality with low 9-cis
β-carotene content might be circumvented by developing low-cost,
controlled light-emitting diode (LED)-based lighting for use in OPRs,
because D. salina will increase the content of 9-cis β-carotene relative to
all-trans β-carotene 3.5-fold and simultaneously increase the total
Table 6
Available wastewater treatment options.
Option CAPEX OPEX Suitable for
recycle/re-use
Suitable for
discharge
Non-oxidising biocide + ++ No No
Membranes +++ + Yes Yes
Ozone (or Peroxide) Low
salinity
+ ++ Yes No
Ozone (or Peroxide)
High salinity
++ +++ Yes No
Chlorine + + Yes No
Chlorine dioxide + ++ Yes No
Peracetic acid + ++ Yes No
Aerobic treatment ++ ++ Yes Yes
Anaerobic treatment (of
sludge)
+++ + No No
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content of carotenoids in biomass when cultivated under red light
(625–680 nm). The absolute amount of 9-cis β-carotene increases ~5-
fold, without requiring nutrient limitation, sub-optimal temperatures or
excessive salt concentrations [59–61]. The effect of an increase in 9-cis
β-carotene is evident even under very low intensity red light (ca.
10–17 μmol m−2 s−1). Red light appears not only to support the growth
of D. salina but also to upregulate the entire biosynthetic pathway of
carotenoids, and seemingly involves chlorophyll absorption of red light
photons coupled to oxygen reduction and phytoene desaturation with a
plastoquinol:oxygen oxidoreductase, as well as the upregulation of
phytoene synthase by the red light photoreceptor, phytochrome, which
may also control β-carotene isomerase to increase the rate of conversion
of extant all-trans β-carotene to 9-cis β-carotene [60,62] (see Fig. 4). In
this regard, recent evidence shows that 15-cis phytoene over-accumu-
lates with red light and with the use of herbicides and is likely con-
verted to all-trans- and 9-cis-β-carotene via 9,15-di-cis phytofluene by a
series of isomerisation and desaturation reactions [62].
4. Conclusions
Valorisation of the efficacy of 9-cis β-carotene in treating athero-
sclerosis, psoriasis, inhibiting atherogenesis and retinitis pigmentosa is
becoming increasingly urgent. We have estimated that the sale of 9-cis
β-carotene oil extracted from Dunaliella biomass could generate an in-
come exceeding 30 million € p.a. Furthermore, after extraction of the 9-
cis β-carotene oil, the remaining defatted biomass offers a potential
source of protein/carbohydrates, which could be more effective for
food/feed applications compared to the corresponding synthetic var-
iants and offer large opportunities to formulate new types of feed
products. The worldwide production of feed is 1 billion tonnes per year
(International Feed Industry Association, www.ifif.org), and conse-
quently the potential added value for EU/world is high.
Sustainable low cost production of D. salina using improved pond
designs with flue gas CO2 combined with heating/cooling for all-year-
round cultivation at optimal temperatures and use of high-quality salt,
as described by the D-Factory biorefinery project, shows the potential
for at least doubling the levels of productivity normally achieved in
industrial-scale cultivation, whilst savings of up to 90% of greenhouse
gas emissions and other environmental impacts, compared to the state
of the art, seem achievable over the next years.
Use of high density inoculum enriched in high 9-cis β-carotene
strains for D. salina combined with development of new LED-based D.
salina cultivation technology suited to OPR cultivation offers further
potential in cultivation for delivering reproducible, low-cost bio-based
production of D. salina biomass, with a consistently high relative con-
tent of 9-cis β-carotene. This could alleviate to some extent the techno-
economic and environmental problems identified with its downstream
purification. Realisation of these findings will require active engage-
ment with multiple stakeholder groups, over several years, as well as
larger-scale projects to develop the technologies and collate the data
needed to support acquisition of a Medicine Licence to prepare the
market for entry of novel 9-cis β-carotene products.
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